Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 6/2020

23.09.2020 | Clinical Review

Epidemiology of esophageal cancer: update in global trends, etiology and risk factors

verfasst von: Dustin J. Uhlenhopp, Eric Omar Then, Tagore Sunkara, Vinaya Gaduputi

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Esophageal cancer is the eighth most common type of cancer worldwide and constitutes the sixth leading cause of cancer deaths. It is characterized by its high mortality rate, poor prognosis at time of diagnosis and variability based on geographic location. Present day, the prevalence of esophageal cancer is in transition. Although esophageal squamous cell carcinoma continues to be the most prevalent type worldwide, esophageal adenocarcinoma is quickly becoming the most prevalent type in developed countries. Risk factors for the development of esophageal squamous cell carcinoma include low socioeconomic status, consumption of tobacco, alcohol, hot beverages, and nitrosamines. Additionally, micronutrient deficiencies have also been linked to the development of esophageal squamous cell cancer. These include vitamin C, vitamin E, and folate. With respect to esophageal adenocarcinoma, risk factors include Barrett's esophagus, gastroesophageal reflux disease, obesity, and tobacco consumption. Screening for esophageal cancer will likely play an essential role in prevention, and consequently, mortality in the future. Present day, there are no established guidelines for esophageal squamous cell cancer screening. Guidelines for esophageal adenocarcinoma are more well established but lack concrete evidence in the form of randomized controlled trials. This review will discuss the epidemiology, risk factors, and current prevention strategies for esophageal cancer in depth. It is our aim to raise awareness on the aforementioned topics to increase public health efforts in eradicating this disease.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed
2.
Zurück zum Zitat Umar S, Fleischer D. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Rev GastroenterolHepatol. 2008;5:517–26.CrossRef Umar S, Fleischer D. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Rev GastroenterolHepatol. 2008;5:517–26.CrossRef
3.
Zurück zum Zitat Ilson DH, van Hillegersberg R. Management of patients with adenocarcinoma or squamous cancer of the esophagus. Gastroenterology. 2018;154:437–51.PubMedCrossRef Ilson DH, van Hillegersberg R. Management of patients with adenocarcinoma or squamous cancer of the esophagus. Gastroenterology. 2018;154:437–51.PubMedCrossRef
4.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Accessed 23 February 2020. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD, https://​seer.​cancer.​gov/​csr/​1975_​2016/​, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Accessed 23 February 2020.
5.
Zurück zum Zitat Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J GastroenterolHepatol. 2016;31:1141–6. Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J GastroenterolHepatol. 2016;31:1141–6.
6.
Zurück zum Zitat Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann ThoracSurg. 2003;76:S1367–S13691369.CrossRef Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann ThoracSurg. 2003;76:S1367–S13691369.CrossRef
7.
Zurück zum Zitat Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.PubMedCrossRef Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.PubMedCrossRef
8.
Zurück zum Zitat Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available from: https://gco.iarc.fr/today. Accessed 05 March 2020. Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, France. Available from: https://​gco.​iarc.​fr/​today. Accessed 05 March 2020.
9.
Zurück zum Zitat Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.PubMedCentralCrossRef Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.PubMedCentralCrossRef
10.
Zurück zum Zitat Montgomery EA (2014) Oesophageal Cancer. In: Stewart BW, Wild CP (Eds) World Cancer Report 2014. World Health Organization. p 374–82. Montgomery EA (2014) Oesophageal Cancer. In: Stewart BW, Wild CP (Eds) World Cancer Report 2014. World Health Organization. p 374–82.
12.
Zurück zum Zitat Arnold M, Laversanne M, Brown LM, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247–55.PubMedCrossRef Arnold M, Laversanne M, Brown LM, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112:1247–55.PubMedCrossRef
13.
Zurück zum Zitat Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. 2018. Available from: https://gco.iarc.fr/tomorrow, accessed 15 March 2020. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. 2018. Available from: https://​gco.​iarc.​fr/​tomorrow, accessed 15 March 2020.
14.
Zurück zum Zitat Gavin AT, Francisci S, Foschi R, et al. EUROCARE-4 Working Group. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.PubMedCrossRef Gavin AT, Francisci S, Foschi R, et al. EUROCARE-4 Working Group. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.PubMedCrossRef
15.
Zurück zum Zitat Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–5.PubMedCrossRef Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210–5.PubMedCrossRef
16.
Zurück zum Zitat Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41:1706–18.PubMedPubMedCentralCrossRef Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41:1706–18.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352–8.PubMedPubMedCentralCrossRef Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17:352–8.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Lindkvist B, Johansen D, Stocks T, et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer. 2014;14:103.PubMedPubMedCentralCrossRef Lindkvist B, Johansen D, Stocks T, et al. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer. 2014;14:103.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Steffen A, Schulze MB, Pischon T, et al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009;18:2079–89.PubMedCrossRef Steffen A, Schulze MB, Pischon T, et al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2009;18:2079–89.PubMedCrossRef
20.
Zurück zum Zitat Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? SeminRadiat Oncol. 2007;17:38–44. Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? SeminRadiat Oncol. 2007;17:38–44.
21.
Zurück zum Zitat Arnold M, Colquhoun A, Cook MB, et al. Obesity and the incidence of upper gastrointestinal cancers: an ecological approach to examine differences across age and sex. Cancer Epidemiol Biomarkers Prev. 2016;25:90–7.PubMedCrossRef Arnold M, Colquhoun A, Cook MB, et al. Obesity and the incidence of upper gastrointestinal cancers: an ecological approach to examine differences across age and sex. Cancer Epidemiol Biomarkers Prev. 2016;25:90–7.PubMedCrossRef
22.
Zurück zum Zitat Cronin-Fenton DP, Murray LJ, Whiteman DC, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010;46:2067–76.PubMedPubMedCentralCrossRef Cronin-Fenton DP, Murray LJ, Whiteman DC, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010;46:2067–76.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Dhillon PK, Farrow DC, Vaughan TL, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001;93:148–52.PubMedCrossRef Dhillon PK, Farrow DC, Vaughan TL, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001;93:148–52.PubMedCrossRef
24.
Zurück zum Zitat Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol. 2013;24:2651–6.PubMedCrossRef Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol. 2013;24:2651–6.PubMedCrossRef
25.
Zurück zum Zitat Chen T, Cheng H, Chen X, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep. 2015;5:16038.PubMedPubMedCentralCrossRef Chen T, Cheng H, Chen X, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep. 2015;5:16038.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Su Z, Zou GR, Mao YP, et al. Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer. 2019;10:1349–57.PubMedPubMedCentralCrossRef Su Z, Zou GR, Mao YP, et al. Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer. 2019;10:1349–57.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Jia N, Wen X, Zhang N, et al. Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. Chin Med J (Engl). 2014;127:2779–833. Jia N, Wen X, Zhang N, et al. Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. Chin Med J (Engl). 2014;127:2779–833.
28.
Zurück zum Zitat Jiang X, Tseng CC, Bernstein L, et al. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer. 2014;14:60.PubMedPubMedCentralCrossRef Jiang X, Tseng CC, Bernstein L, et al. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer. 2014;14:60.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Turati F, Negri E, La Vecchia C. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14:1–4.PubMedCrossRef Turati F, Negri E, La Vecchia C. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14:1–4.PubMedCrossRef
30.
Zurück zum Zitat Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–6.PubMedCrossRef Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–6.PubMedCrossRef
31.
Zurück zum Zitat Buas MF, He Q, Johnson LG, et al. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017;66:1739–47.PubMedCrossRef Buas MF, He Q, Johnson LG, et al. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017;66:1739–47.PubMedCrossRef
32.
Zurück zum Zitat Lewis SJ, Smith GD. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005;14:1967–71.PubMedCrossRef Lewis SJ, Smith GD. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005;14:1967–71.PubMedCrossRef
33.
Zurück zum Zitat Blot WJ, Tarone RE. Esophageal cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors. Cancer epidemiology and prevention. 4th ed. New York: Oxford University Press; 2018. p. 579–592. Blot WJ, Tarone RE. Esophageal cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors. Cancer epidemiology and prevention. 4th ed. New York: Oxford University Press; 2018. p. 579–592.
34.
Zurück zum Zitat Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.PubMedCrossRef Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.PubMedCrossRef
35.
Zurück zum Zitat Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. SeminRadiat Oncol. 2007;17:2–9. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. SeminRadiat Oncol. 2007;17:2–9.
36.
Zurück zum Zitat Choi YJ, Lee DH, Han K-D, et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS ONE. 2017;12:e0185778.PubMedPubMedCentralCrossRef Choi YJ, Lee DH, Han K-D, et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS ONE. 2017;12:e0185778.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Pandeya N, Williams G, Green AC, et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136:1215–24.PubMedCrossRef Pandeya N, Williams G, Green AC, et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136:1215–24.PubMedCrossRef
38.
Zurück zum Zitat Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135–44.PubMedCrossRef Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135–44.PubMedCrossRef
39.
Zurück zum Zitat DomperArnal MJ, Arenas F, Arbeloa L. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–43.CrossRef DomperArnal MJ, Arenas F, Arbeloa L. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–43.CrossRef
40.
Zurück zum Zitat Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.PubMedCrossRef Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.PubMedCrossRef
41.
Zurück zum Zitat Pandeya N, Olsen CM, Whiteman DC. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol. 2013;37:579–84.PubMedCrossRef Pandeya N, Olsen CM, Whiteman DC. Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol. 2013;37:579–84.PubMedCrossRef
42.
Zurück zum Zitat Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res ClinGastroenterol. 2017;31:509–17.CrossRef Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res ClinGastroenterol. 2017;31:509–17.CrossRef
43.
Zurück zum Zitat Bosetti C, Gallus S, Garavello W, et al. Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol. 2006;42:957–64.PubMedCrossRef Bosetti C, Gallus S, Garavello W, et al. Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol. 2006;42:957–64.PubMedCrossRef
44.
Zurück zum Zitat Hardikar S, Onstad L, Blount PL, et al (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PloS one. 8. Hardikar S, Onstad L, Blount PL, et al (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PloS one. 8.
45.
Zurück zum Zitat Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. JNCI J Natl Cancer Inst. 2010;102:1344–53. https://doi.org/10.1093/jnci/djq289.CrossRefPubMed Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. JNCI J Natl Cancer Inst. 2010;102:1344–53. https://​doi.​org/​10.​1093/​jnci/​djq289.CrossRefPubMed
46.
Zurück zum Zitat Liu J, Wang J, Leng Y, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133:473–85.PubMedCrossRef Liu J, Wang J, Leng Y, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133:473–85.PubMedCrossRef
47.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. Available at https://dietandcancerreport.org. Accessed 24 Aug 2020. World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018. Available at https://​dietandcancerrep​ort.​org. Accessed 24 Aug 2020.
48.
Zurück zum Zitat Zhao Y, Guo C, Hu H, et al. Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis. Oncotarget. 2017;8:10458–69.PubMedCrossRefPubMedCentral Zhao Y, Guo C, Hu H, et al. Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis. Oncotarget. 2017;8:10458–69.PubMedCrossRefPubMedCentral
49.
Zurück zum Zitat Zgaga L, O'Sullivan F, Cantwell MM, et al. Markers of Vitamin D exposure and esophageal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25:877–86.PubMedCrossRef Zgaga L, O'Sullivan F, Cantwell MM, et al. Markers of Vitamin D exposure and esophageal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25:877–86.PubMedCrossRef
50.
Zurück zum Zitat Chen Y, Tong Y, Yang C, et al. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC cancer. 2015;15:449.PubMedPubMedCentralCrossRef Chen Y, Tong Y, Yang C, et al. Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. BMC cancer. 2015;15:449.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Zhang J, Zhou B, Hao C. Coffee consumption and risk of esophageal cancer incidence: a meta-analysis of epidemiologic studies. Medicine (Baltimore). 2018;97:e0514.CrossRef Zhang J, Zhou B, Hao C. Coffee consumption and risk of esophageal cancer incidence: a meta-analysis of epidemiologic studies. Medicine (Baltimore). 2018;97:e0514.CrossRef
52.
Zurück zum Zitat Qu X, Ben Q, Jiang Y. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. Ann Epidemiol. 2013;23:762–70.PubMedCrossRef Qu X, Ben Q, Jiang Y. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. Ann Epidemiol. 2013;23:762–70.PubMedCrossRef
53.
Zurück zum Zitat Kubo A, Levin TR, Block G, et al. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008;167:839–46.PubMedCrossRef Kubo A, Levin TR, Block G, et al. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008;167:839–46.PubMedCrossRef
54.
Zurück zum Zitat Pan D, Su M, Zhang T, et al. A distinct epidemiologic pattern of precancerous lesions of esophageal squamous cell carcinoma in a high-risk area of Huai'an, Jiangsu Province, China. Cancer Prev Res (Phila). 2019;12:449–62.CrossRef Pan D, Su M, Zhang T, et al. A distinct epidemiologic pattern of precancerous lesions of esophageal squamous cell carcinoma in a high-risk area of Huai'an, Jiangsu Province, China. Cancer Prev Res (Phila). 2019;12:449–62.CrossRef
55.
Zurück zum Zitat Marshall B, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;323(8390):1311–5.CrossRef Marshall B, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;323(8390):1311–5.CrossRef
57.
Zurück zum Zitat Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.PubMedCrossRef Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.PubMedCrossRef
58.
Zurück zum Zitat Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329–38.CrossRef Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329–38.CrossRef
59.
Zurück zum Zitat Nie S, Chen T, Yang X, et al. Association of helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2014;27:645–53.PubMedCrossRef Nie S, Chen T, Yang X, et al. Association of helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2014;27:645–53.PubMedCrossRef
60.
Zurück zum Zitat Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.PubMedCrossRef Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–82.PubMedCrossRef
61.
Zurück zum Zitat Kastelein F, Spaander MC, Biermann K, et al. Probar-study Group. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011;141:2000–8.PubMedCrossRef Kastelein F, Spaander MC, Biermann K, et al. Probar-study Group. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011;141:2000–8.PubMedCrossRef
62.
Zurück zum Zitat Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010;138:2260–6.PubMedCrossRef Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010;138:2260–6.PubMedCrossRef
63.
Zurück zum Zitat Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014;63:1229–377.PubMedCrossRef Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014;63:1229–377.PubMedCrossRef
64.
Zurück zum Zitat Lacroix O, Couttenier A, Vaes E, et al. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study. Cancer Causes Control. 2019;30:385–93.PubMedCrossRef Lacroix O, Couttenier A, Vaes E, et al. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study. Cancer Causes Control. 2019;30:385–93.PubMedCrossRef
65.
Zurück zum Zitat Wheeler JB, Reed CE. Epidemiology of esophageal cancer. SurgClin North Am. 2012;92:1077–87.CrossRef Wheeler JB, Reed CE. Epidemiology of esophageal cancer. SurgClin North Am. 2012;92:1077–87.CrossRef
66.
Zurück zum Zitat Lee CH, Lee JM, Wu DC, et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer. 2005;113:475–82.PubMedCrossRef Lee CH, Lee JM, Wu DC, et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer. 2005;113:475–82.PubMedCrossRef
67.
Zurück zum Zitat Offermans NS, Vermeulen R, Burdorf A, et al. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands Cohort Study. Int J Cancer. 2014;135:1970–7.PubMedCrossRef Offermans NS, Vermeulen R, Burdorf A, et al. Occupational asbestos exposure and risk of esophageal, gastric and colorectal cancer in the prospective Netherlands Cohort Study. Int J Cancer. 2014;135:1970–7.PubMedCrossRef
68.
Zurück zum Zitat Roshandel G, Semnani S, Malekzadeh R, et al. Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med. 2012;15:713–22.PubMedPubMedCentral Roshandel G, Semnani S, Malekzadeh R, et al. Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med. 2012;15:713–22.PubMedPubMedCentral
69.
Zurück zum Zitat Jansson C, Plato N, Johansson AL, et al. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma. Occup Environ Med. 2006;63:107–12.PubMedPubMedCentralCrossRef Jansson C, Plato N, Johansson AL, et al. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma. Occup Environ Med. 2006;63:107–12.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma—precursor lesions and early diagnosis. World J GastrointestEndosc. 2012;4:9–16.CrossRef Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma—precursor lesions and early diagnosis. World J GastrointestEndosc. 2012;4:9–16.CrossRef
71.
Zurück zum Zitat Hamel C, Ahmadzai N, Beck A, et al. (2020) Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev. 9. Hamel C, Ahmadzai N, Beck A, et al. (2020) Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev. 9.
73.
Zurück zum Zitat Gavin AT, Francisci S, Foschi R, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.PubMedCrossRef Gavin AT, Francisci S, Foschi R, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36:505–12.PubMedCrossRef
74.
Zurück zum Zitat Hou H, Meng Z, Zhao X, et al. Survival of esophageal cancer in China: a pooled analysis on hospital-based studies From 2000 to 2018. Front Oncol. 2019;9:548.PubMedPubMedCentralCrossRef Hou H, Meng Z, Zhao X, et al. Survival of esophageal cancer in China: a pooled analysis on hospital-based studies From 2000 to 2018. Front Oncol. 2019;9:548.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Qin J, Zhu HD, Guo JH, et al. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis. Dis Esophagus. 2019;32:doz012.PubMed Qin J, Zhu HD, Guo JH, et al. Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis. Dis Esophagus. 2019;32:doz012.PubMed
77.
Zurück zum Zitat Asombang AW, Chishinga N, Nkhoma A, et al. Systematic review and meta-analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes. World J Gastroenterol. 2019;25:4512–33.PubMedPubMedCentralCrossRef Asombang AW, Chishinga N, Nkhoma A, et al. Systematic review and meta-analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes. World J Gastroenterol. 2019;25:4512–33.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:390–405.PubMedCrossRef Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154:390–405.PubMedCrossRef
79.
Zurück zum Zitat Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015;136:1921–30.PubMedCrossRef Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003–2005: a population-based study. Int J Cancer. 2015;136:1921–30.PubMedCrossRef
80.
Zurück zum Zitat Van Loon K, Mwachiro MM, Abnet CC, et al. The African esophageal cancer consortium: a call to action. J Glob Oncol. 2018;4:1–9.PubMed Van Loon K, Mwachiro MM, Abnet CC, et al. The African esophageal cancer consortium: a call to action. J Glob Oncol. 2018;4:1–9.PubMed
81.
Zurück zum Zitat Chung CS, Lee YC, Wu MS. Prevention strategies for esophageal cancer: perspectives of the East vs West. Best Pract Res ClinGastroenterol. 2015;29:869–83.CrossRef Chung CS, Lee YC, Wu MS. Prevention strategies for esophageal cancer: perspectives of the East vs West. Best Pract Res ClinGastroenterol. 2015;29:869–83.CrossRef
82.
Zurück zum Zitat Siti-Azrin AH, Wan-Nor-Asyikeen WA, Norsa'adah B. Review of the burden of esophageal cancer in Malaysia. Asian Pac J Cancer Prev. 2016;17:3705–9.PubMed Siti-Azrin AH, Wan-Nor-Asyikeen WA, Norsa'adah B. Review of the burden of esophageal cancer in Malaysia. Asian Pac J Cancer Prev. 2016;17:3705–9.PubMed
83.
Zurück zum Zitat Guo LW, Huang HY, Shi JF, et al. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011). Chin J Cancer. 2017;36:73.PubMedPubMedCentralCrossRef Guo LW, Huang HY, Shi JF, et al. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011). Chin J Cancer. 2017;36:73.PubMedPubMedCentralCrossRef
84.
Zurück zum Zitat Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360–73.PubMedCrossRef Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360–73.PubMedCrossRef
85.
Zurück zum Zitat Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27:215–21.PubMedCrossRef Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27:215–21.PubMedCrossRef
86.
Zurück zum Zitat Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16:1–24.PubMedCrossRef Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16:1–24.PubMedCrossRef
87.
Zurück zum Zitat Bo Y, Lu Y, Zhao Y, et al. Association between dietary vitamin C intake and risk of esophageal cancer: a dose-response meta-analysis. Int J Cancer. 2016;138:1843–50.PubMedCrossRef Bo Y, Lu Y, Zhao Y, et al. Association between dietary vitamin C intake and risk of esophageal cancer: a dose-response meta-analysis. Int J Cancer. 2016;138:1843–50.PubMedCrossRef
88.
Zurück zum Zitat Deng HY, Lan X, Zheng X, et al. The association between statin use and survival of esophageal cancer patients: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e16480.CrossRef Deng HY, Lan X, Zheng X, et al. The association between statin use and survival of esophageal cancer patients: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e16480.CrossRef
89.
Zurück zum Zitat Yang W, Han Y, Zhao X, et al. Advances in prognostic biomarkers for esophageal cancer. Expert Rev MolDiagn. 2019;19:109–19.CrossRef Yang W, Han Y, Zhao X, et al. Advances in prognostic biomarkers for esophageal cancer. Expert Rev MolDiagn. 2019;19:109–19.CrossRef
Metadaten
Titel
Epidemiology of esophageal cancer: update in global trends, etiology and risk factors
verfasst von
Dustin J. Uhlenhopp
Eric Omar Then
Tagore Sunkara
Vinaya Gaduputi
Publikationsdatum
23.09.2020
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 6/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-020-01237-x

Weitere Artikel der Ausgabe 6/2020

Clinical Journal of Gastroenterology 6/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.